Drug Profile
Diclofenac/tolperisone controlled release
Alternative Names: Diclofenac SR/tolperisone SR; Diclofenac/tolperisone sustained release; Tolperisone SR/diclofenac SR; Tolperisone/diclofenac controlled release; Tolperisone/diclofenac sustained releaseLatest Information Update: 21 Apr 2015
Price :
$50
*
At a glance
- Originator Inventia Healthcare
- Class Analgesics; Antirheumatics; Antiseptics; Antispasmodics; Muscle relaxants; Nonsteroidal anti-inflammatories; Phenylacetates; Propiophenones; Pyridines; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute pain
Most Recent Events
- 21 Apr 2015 No recent reports of development identified - Phase-III for Acute pain in India (PO)
- 27 Jan 2012 Inventia Healthcare completes a phase III trial in Acute pain (low back pain) in India (CTRI2011-10-002074)
- 20 Oct 2011 Phase-III clinical trials in Acute pain in India (PO)